Novel Biomarker for Gastric Cancer: Programmed death 1(PD-L1)

Item Number: 611
Industry: Diagnostic
Category: Oncology
Development Stage: Research
Organisation Type: Private Corporation
Country: South Korea
Patent: Korea, PCT
Business Opportunity: Out-Licensing, Collaboration R&D


Researher has explored the relationship between PD-1’s receptor, PD-L1 expression and MSI-H gastric carcinomas, to determine if the former could be developed as a potential predictive biomarker in determining the prognosis of patients with this tumor subtype.

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it